Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Recommendation of “Moderate Buy” by Brokerages
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) has received an average rating of “Moderate Buy” from the eight ratings firms that are presently covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 12-month price […]
More Stories
Middlefield Banc (NASDAQ:MBCN) Upgraded at StockNews.com
StockNews.com upgraded shares of Middlefield Banc (NASDAQ:MBCN – Free Report) from a sell rating to a hold rating in a...
StockNews.com Begins Coverage on Origin Agritech (NASDAQ:SEED)
StockNews.com started coverage on shares of Origin Agritech (NASDAQ:SEED – Free Report) in a report published on Saturday. The firm...
Mastech Digital (NYSE:MHH) Research Coverage Started at StockNews.com
StockNews.com started coverage on shares of Mastech Digital (NYSE:MHH – Free Report) in a research report report published on Saturday....
StockNews.com Upgrades VF (NYSE:VFC) to Hold
StockNews.com upgraded shares of VF (NYSE:VFC – Free Report) from a sell rating to a hold rating in a report...
Aptiv (NYSE:APTV) Earns Hold Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Aptiv (NYSE:APTV – Free Report) in a research report sent to investors on Saturday....
Amprius Technologies (NYSE:AMPX) vs. Ilika (OTCMKTS:ILIKF) Financial Analysis
Amprius Technologies (NYSE:AMPX – Get Free Report) and Ilika (OTCMKTS:ILIKF – Get Free Report) are both industrials companies, but which...